Skip to content

Assessment of Biotin Interference in thyroid Immunoassays

Assessment of Biotin Interference in thyroid Immunoassays

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020472
Enrollment
Unknown
Registered
2018-12-31
Start date
2018-12-26
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid disease

Interventions

Case series:Oral biotin

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) healthy adults between the ages of 18-50, normal liver and renal function, signed the informed consent; (2) The results of thyroid function tests and anti-thyroid antibodies before biotin administration within the normal range.

Exclusion criteria

Exclusion criteria: (1) being treated with any medicine (including dietary or nutritional supplements) or significant iodine intake in the past 1 months; (2) smoking or alcohol abuse history; (3) working the night shiftor; (4) hyroid ultrasonography suggested Graves' disease, hashimoto's thyroiditis, subacute thyroiditis and other diseases that may cause thyroid function changes; (5) pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
thyroid function tests and anti-thyroid antibodies;

Countries

China

Contacts

Public ContactQing Wang

China-Japan Union Hospital of Jilin University

wangqing5151@126.com+86 13614301117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026